Ivonescimab Injection
SMT112-3003
Phase 3 mab active
Quick answer
Ivonescimab Injection for Non-Small Cell Lung Cancer is a Phase 3 program (mab) at Summit Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Summit Therapeutics
- Indication
- Non-Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- active